The HIT antibody is a platelet-activating antibody involved in the development of heparin-induced thrombocytopenia (HIT). HIT is a serious autoimmune disease in which heparin administered for anticoagulant purposes, which produces HIT antibodies through an immunological mechanism, instead causes a tendency toward thrombosis, resulting in thrombocytopenia or thromboembolism. If it develops, nearly half may become complicated by thromboembolism, which can lead to death, and appropriate clinical and laboratory diagnosis is required. HIT antibodies prepared by the latex agglutination method measure all fractions of IgG, IgA, and IgM.


